個股熱度排行 | 8月5日港股盤前
根據uSMART輿情監測數據，從4日晚間到5日港股盤前時間段，市場關注指數最高的5只股票是阿裏巴巴-SW、百濟神州、廣汽集團、中國恆大、信達生物。
8月5日—港股關注排行TOP5
阿裏巴巴-SW
關注度第一爲阿裏巴巴-SW，該股上個交易日收盤上漲5.15%，報於95.00港元。近5個交易日累計下跌4.19%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
阿裏巴巴-SW首季淨利潤227.39億元 同比減少約50%
軟銀通過出售阿裏巴巴衍生品融資220億美元
百濟神州
關注度第二爲百濟神州，該股上個交易日收盤上漲3.38%，報於104.00港元。近5個交易日累計下跌1.42%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
百濟神州BTK百悅澤上半年全球收入2.331億美元 在美銷售額同比增長5倍
百濟神州上季收入增1.2倍至3億美元 季內淨虧損擴大兩成至5.7億美元
廣汽集團
關注度第三爲廣汽集團，該股上個交易日收盤上漲0.27%，報於7.51港元。近5個交易日累計上漲1.76%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
廣汽集團7月汽車銷量達22.01萬輛、埃安新能源銷量同比增長138.27%
廣汽7月新能源車銷售增127%至2.7萬輛 月內汽車整體銷量增22%
中國恆大
關注度第四爲中國恆大，該股上個交易日收盤上漲8.55%，報於1.65港元。近5個交易日累計上漲13.01%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
恆大退還足球場地塊 虧本回收55.2億退庫款
恆大退還廣州恆大足球場使用權 料錄得12.55億人幣虧損
信達生物
關注度第五爲信達生物，該股上個交易日收盤上漲2.82%，報於32.85港元。近5個交易日累計下跌2.95%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
信達生物與賽諾菲集團達成多項目戰略合作及許可協議
信達生物與賽諾菲達成戰略合作：加速腫瘤新藥開發，攜手拓展中國市場
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
